eLife (Jul 2020)

α-synuclein strains that cause distinct pathologies differentially inhibit proteasome

  • Genjiro Suzuki,
  • Sei Imura,
  • Masato Hosokawa,
  • Ryu Katsumata,
  • Takashi Nonaka,
  • Shin-Ichi Hisanaga,
  • Yasushi Saeki,
  • Masato Hasegawa

DOI
https://doi.org/10.7554/eLife.56825
Journal volume & issue
Vol. 9

Abstract

Read online

Abnormal α-synuclein aggregation has been implicated in several diseases and is known to spread in a prion-like manner. There is a relationship between protein aggregate structure (strain) and clinical phenotype in prion diseases, however, whether differences in the strains of α-synuclein aggregates account for the different pathologies remained unclear. Here, we generated two types of α-synuclein fibrils from identical monomer and investigated their seeding and propagation ability in mice and primary-cultured neurons. One α-synuclein fibril induced marked accumulation of phosphorylated α-synuclein and ubiquitinated protein aggregates, while the other did not, indicating the formation of α-synuclein two strains. Notably, the former α-synuclein strain inhibited proteasome activity and co-precipitated with 26S proteasome complex. Further examination indicated that structural differences in the C-terminal region of α-synuclein strains lead to different effects on proteasome activity. These results provide a possible molecular mechanism to account for the different pathologies induced by different α-synuclein strains.

Keywords